Biolife Solutions (BLFS) Short-term Investments (2014 - 2026)

Biolife Solutions (BLFS) has reported Short-term Investments for 9 consecutive years, with $58.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments rose 168.89% year-over-year to $58.2 million; the TTM figure through Mar 2026 stood at $58.2 million (up 168.89% YoY), while the FY2025 annual figure was $55.9 million, up 507.62% from the prior year.
• Short-term Investments improved to $58.2 million in Q1 2026 per BLFS's latest filing, from $55.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $58.2 million in Q1 2026 and bottomed at $10000.0 in Q1 2022.
• Historically, Short-term Investments has averaged $24.5 million across 5 years, with a median of $21.8 million in 2023.
• Annual changes were most pronounced in 2023 — Short-term Investments surged 357700.0% — and 2024, when it sank 99.88%.
• Biolife Solutions' Short-term Investments stood at $31000.0 in 2022, then jumped by 52441.94% to $16.3 million in 2023, then tumbled by 43.53% to $9.2 million in 2024, then jumped by 507.62% to $55.9 million in 2025, then climbed by 4.09% to $58.2 million in 2026.
• Business Quant data shows BLFS's Short-term Investments at $58.2 million in Q1 2026, $55.9 million in Q4 2025, and $49.5 million in Q3 2025.